$FA
FIRST ADVANTAGE CORP

2023 Q2 Form 10-Q Financial Statement

#000095017023020564 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $185.3M $175.5M
YoY Change -8.06% -7.56%
Cost Of Revenue $93.00M $91.06M
YoY Change -7.27% -5.57%
Gross Profit $92.32M $84.46M
YoY Change -8.84% -9.62%
Gross Profit Margin 49.82% 48.12%
Selling, General & Admin $29.98M $28.68M
YoY Change -3.71% 0.48%
% of Gross Profit 32.48% 33.96%
Research & Development $12.64M $12.62M
YoY Change -2.34% -8.34%
% of Gross Profit 13.7% 14.95%
Depreciation & Amortization $16.60M $16.40M
YoY Change -4.05% -2.38%
% of Gross Profit 17.98% 19.42%
Operating Expenses $167.7M $164.2M
YoY Change -6.21% -4.95%
Operating Profit $17.64M $11.29M
YoY Change -22.58% -33.99%
Interest Expense -$3.887M -$8.681M
YoY Change 24.9% -1121.29%
% of Operating Profit -22.04% -76.91%
Other Income/Expense, Net -$3.887M -$8.681M
YoY Change 24.9% -1121.29%
Pretax Income $13.75M $2.606M
YoY Change -30.09% -85.48%
Income Tax $3.968M $681.0K
% Of Pretax Income 28.86% 26.13%
Net Earnings $9.782M $1.925M
YoY Change -31.29% -85.21%
Net Earnings / Revenue 5.28% 1.1%
Basic Earnings Per Share $0.07 $0.01
Diluted Earnings Per Share $0.07 $0.01
COMMON SHARES
Basic Shares Outstanding 146.3M 147.8M
Diluted Shares Outstanding 145.3M 147.0M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $401.2M $402.1M
YoY Change 13.61% 30.3%
Cash & Equivalents $399.1M $400.2M
Short-Term Investments $2.153M $1.954M
Other Short-Term Assets $21.61M $22.92M
YoY Change -8.43% 18.53%
Inventory
Prepaid Expenses
Receivables $140.0M $128.0M
Other Receivables $8.959M $2.482M
Total Short-Term Assets $571.7M $555.5M
YoY Change 9.37% 16.29%
LONG-TERM ASSETS
Property, Plant & Equipment $93.27M $103.3M
YoY Change -31.69% -29.44%
Goodwill $793.6M $793.3M
YoY Change -0.37% -1.17%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.49M $11.24M
YoY Change -49.31% -48.75%
Total Long-Term Assets $1.266B $1.292B
YoY Change -8.79% -9.36%
TOTAL ASSETS
Total Short-Term Assets $571.7M $555.5M
Total Long-Term Assets $1.266B $1.292B
Total Assets $1.838B $1.848B
YoY Change -3.82% -2.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $51.93M $47.48M
YoY Change 4.84% -7.71%
Accrued Expenses $15.66M $16.78M
YoY Change -11.91% -6.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $90.11M $84.96M
YoY Change -11.17% -15.4%
LONG-TERM LIABILITIES
Long-Term Debt $557.6M $557.1M
YoY Change 0.33% 0.33%
Other Long-Term Liabilities $3.012M $3.170M
YoY Change -2.96% -6.93%
Total Long-Term Liabilities $560.6M $560.3M
YoY Change 0.31% 0.28%
TOTAL LIABILITIES
Total Short-Term Liabilities $90.11M $84.96M
Total Long-Term Liabilities $560.6M $560.3M
Total Liabilities $744.0M $740.3M
YoY Change -2.05% -2.23%
SHAREHOLDERS EQUITY
Retained Earnings -$68.51M -$50.95M
YoY Change 1534.26% 176.5%
Common Stock $1.184B $1.180B
YoY Change 1.16% 1.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.094B $1.107B
YoY Change
Total Liabilities & Shareholders Equity $1.838B $1.848B
YoY Change -3.82% -2.92%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $9.782M $1.925M
YoY Change -31.29% -85.21%
Depreciation, Depletion And Amortization $16.60M $16.40M
YoY Change -4.05% -2.38%
Cash From Operating Activities $33.12M $38.60M
YoY Change -39.59% -7.18%
INVESTING ACTIVITIES
Capital Expenditures $7.024M $42.00K
YoY Change -189.49% -98.56%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$211.0K -$15.00K
YoY Change 402.38% -99.92%
Cash From Investing Activities -$7.235M -$6.083M
YoY Change -8.31% -77.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -26.82M -24.16M
YoY Change -11915.42% 60307.5%
NET CHANGE
Cash From Operating Activities 33.12M 38.60M
Cash From Investing Activities -7.235M -6.083M
Cash From Financing Activities -26.82M -24.16M
Net Change In Cash -933.0K 8.500M
YoY Change -101.98% -43.82%
FREE CASH FLOW
Cash From Operating Activities $33.12M $38.60M
Capital Expenditures $7.024M $42.00K
Free Cash Flow $26.10M $38.56M
YoY Change -58.36% -0.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#InterestIncomeExpenseNet
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001210677
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2022#InterestIncomeExpenseNet
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-31666
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
First Advantage Corporation
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3884690
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Concourse Parkway NE
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2023Q1 dei Entity Address Country
EntityAddressCountry
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30328
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
314-9761
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
FA
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146259519
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
400156000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
391655000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
140000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
141000
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
1954000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
1956000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1344000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1348000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
127962000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143811000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22780000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25407000
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
2482000
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
3225000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
555474000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
566195000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103301000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113529000
CY2023Q1 us-gaap Goodwill
Goodwill
793293000
CY2022Q4 us-gaap Goodwill
Goodwill
793080000
CY2023Q1 fa Trade Name Net
TradeNameNet
69387000
CY2022Q4 fa Trade Name Net
TradeNameNet
71162000
CY2023Q1 fa Customer Lists Net
CustomerListsNet
312568000
CY2022Q4 fa Customer Lists Net
CustomerListsNet
326014000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2405000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2422000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11235000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13423000
CY2023Q1 us-gaap Assets
Assets
1847663000
CY2022Q4 us-gaap Assets
Assets
1885825000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
47484000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54947000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12990000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22702000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16782000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16400000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5640000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4957000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
808000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
724000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1256000
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1056000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
84960000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
100786000
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7613000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8075000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
557111000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
556649000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
88422000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
90556000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6673000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7879000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3170000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3337000
CY2023Q1 us-gaap Liabilities
Liabilities
740336000
CY2022Q4 us-gaap Liabilities
Liabilities
759207000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
147026264
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147026264
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
148732603
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
148732603
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
147000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
149000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1179595000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1176163000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50953000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27363000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21462000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-22331000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1107327000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1126618000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1847663000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1885825000
CY2023Q1 us-gaap Revenues
Revenues
175520000
CY2022Q1 us-gaap Revenues
Revenues
189881000
CY2023Q1 fa Cost Of Services Excluding Depreciation And Amortization
CostOfServicesExcludingDepreciationAndAmortization
91061000
CY2022Q1 fa Cost Of Services Excluding Depreciation And Amortization
CostOfServicesExcludingDepreciationAndAmortization
96431000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12624000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13773000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28682000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28545000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31866000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34034000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
164233000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
172783000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11287000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17098000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8681000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
850000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8681000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
850000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2606000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17948000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
681000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4935000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13013000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
869000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1517000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2794000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
11496000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13013000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145862562
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150538700
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147031866
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152348806
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13013000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31866000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
34034000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
461000
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
445000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-40000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-184000
CY2023Q1 fa Deferred Taxes
DeferredTaxes
-2144000
CY2022Q1 fa Deferred Taxes
DeferredTaxes
1698000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2058000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1859000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
411000
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1222000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-163000
CY2023Q1 fa Gain Loss Due To Change In Fair Value Of Interest Rate Swaps
GainLossDueToChangeInFairValueOfInterestRateSwaps
-1879000
CY2022Q1 fa Gain Loss Due To Change In Fair Value Of Interest Rate Swaps
GainLossDueToChangeInFairValueOfInterestRateSwaps
5260000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15980000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8862000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2933000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1151000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7618000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1329000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11828000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-13215000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
209000
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-254000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-110000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-405000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
980000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-26000
CY2023Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
836000
CY2022Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
1442000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38599000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41583000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18920000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2909000
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6056000
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
4643000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-15000
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-0
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6083000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26472000
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
25266000
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
37000
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
238000
CY2023Q1 fa Payments On Deferred Purchase Agreements
PaymentsOnDeferredPurchaseAgreements
234000
CY2022Q1 fa Payments On Deferred Purchase Agreements
PaymentsOnDeferredPurchaseAgreements
349000
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1399000
CY2022Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
547000
CY2023Q1 fa Net Settlement Of Share Based Compensation Plan Awards
NetSettlementOfShareBasedCompensationPlanAwards
-25000
CY2022Q1 fa Net Settlement Of Share Based Compensation Plan Awards
NetSettlementOfShareBasedCompensationPlanAwards
0
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24163000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8500000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15129000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
391796000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
292790000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400296000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
307919000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2049000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1713000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
10625000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4774000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
275000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
206000
CY2023Q1 fa Excise Taxes On Share Repurchases Incurred But Not Paid
ExciseTaxesOnShareRepurchasesIncurredButNotPaid
252000
CY2022Q1 fa Excise Taxes On Share Repurchases Incurred But Not Paid
ExciseTaxesOnShareRepurchasesIncurredButNotPaid
0
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1126618000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2058000
CY2023Q1 fa Share Repurchases
ShareRepurchases
-25517000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1399000
CY2023Q1 fa Additional Paid In Capital Withheld For Tax Obligations And Net Settlement Of Stock Option Exercise
AdditionalPaidInCapitalWithheldForTaxObligationsAndNetSettlementOfStockOptionExercise
-25000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
869000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1107327000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1132238000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1859000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
547000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1517000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13013000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1146140000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> — The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Changes in these estimates and assumptions may have a material impact on the condensed consolidated financial statements and accompanying notes.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant estimates, judgments, and assumptions, include, but are not limited to, the determination of the fair value and useful lives of assets acquired and liabilities assumed through business combinations, revenue recognition, capitalized software, and income tax liabilities and assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates.</span></p>
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1100000
CY2023Q1 fa Write Down Of Abandoned Property And Equipment
WriteDownOfAbandonedPropertyAndEquipment
200000
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:9.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concentrations of Credit Risk — </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. Cash is deposited with major financial institutions and, at times, such balances with each financial institution may be in excess of insured limits. The Company has not experienced, and does not anticipate, any losses with respect to its cash deposits. Accounts receivable represent credit granted to customers for services provided. The Company performs ongoing credit evaluations of its customers’ financial condition and generally does not require collateral on accounts receivable. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have any customers which represented </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% or more of consolidated revenues for the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three months ended March 31, 2023 and 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Additionally, the Company did </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have any customers which represented </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% or more of consolidated accounts receivable, net for any period presented.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
319765000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
313971000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
216464000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
200442000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
103301000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
113529000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16400000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16800000
CY2022Q4 us-gaap Goodwill
Goodwill
793080000
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
213000
CY2023Q1 us-gaap Goodwill
Goodwill
793293000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
610009000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
228054000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
381955000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
609721000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
212545000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
397176000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15400000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17200000
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
7613000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8075000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
557111000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
556649000
CY2020Q1 fa Description Of Borrowing Capacity Not Subject To Net Leverage Ratio Covenant
DescriptionOfBorrowingCapacityNotSubjectToNetLeverageRatioCovenant
In the event the Company’s outstanding indebtedness under the Revolver exceeds 35% of the aggregate principal amount of the revolving commitments then in effect, it is required to maintain a consolidated first lien leverage ratio no greater than 7.75 to 1.00.
CY2023Q1 fa Description Of Borrowing Capacity Not Subject To Net Leverage Ratio Covenant
DescriptionOfBorrowingCapacityNotSubjectToNetLeverageRatioCovenant
As the Company had no outstanding amounts under the Revolver, it was not subject to the consolidated first lien leverage ratio covenant and was compliant with all other covenants under the agreement as of March 31, 2023.
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.275
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 fa Stock Repurchase Price Per Share
StockRepurchasePricePerShare
13.50
CY2023Q1 fa Stock Repurchase Cost Total
StockRepurchaseCostTotal
25228000
CY2023Q1 fa Additional Associated Cost
AdditionalAssociatedCost
289000
CY2023Q1 fa Share Repurchase Cost Recorded To Accumulated Defecit
ShareRepurchaseCostRecordedToAccumulatedDefecit
25517000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7200000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6500000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1300000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1100000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2058000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1859000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
33200000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y8M12D
CY2023Q1 fa Employee Stock Purchase Plan Percent
EmployeeStockPurchasePlanPercent
0.15
CY2023Q1 fa Employee Stock Purchase Plan Expenses
EmployeeStockPurchasePlanExpenses
200000
CY2022Q1 fa Employee Stock Purchase Plan Expenses
EmployeeStockPurchasePlanExpenses
100000
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1871691
CY2023Q1 fa Indemnity Liability
IndemnityLiability
4100000
CY2022Q4 fa Indemnity Liability
IndemnityLiability
4400000
CY2023Q1 us-gaap Related Party Costs
RelatedPartyCosts
0
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.09
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.09
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13013000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145862562
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
150538700
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1169304
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1810106
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147031866
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152348806
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2913298
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2099781
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
175520000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
189881000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
fa-20230331_cal.xml Edgar Link unprocessable
0000950170-23-020564-index-headers.html Edgar Link pending
0000950170-23-020564-index.html Edgar Link pending
0000950170-23-020564.txt Edgar Link pending
0000950170-23-020564-xbrl.zip Edgar Link pending
fa-20230331.htm Edgar Link pending
fa-20230331.xsd Edgar Link pending
fa-ex10_1.htm Edgar Link pending
fa-ex10_2.htm Edgar Link pending
fa-ex10_3.htm Edgar Link pending
fa-ex31_1.htm Edgar Link pending
fa-ex31_2.htm Edgar Link pending
fa-ex32_1.htm Edgar Link pending
fa-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
fa-20230331_def.xml Edgar Link unprocessable
fa-20230331_lab.xml Edgar Link unprocessable
fa-20230331_pre.xml Edgar Link unprocessable
fa-20230331_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending